Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity

Recommendation ID: IPG569/1
Question: NICE encourages further research into single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) for treating morbid obesity, particularly research examining long-term outcomes. NICE may update the guidance on publication of further evidence.
Any explanatory notes (if applicable): Current evidence on the safety of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) for treating morbid obesity shows that there are well-recognised complications. Evidence on efficacy is limited in both quality and quantity. Therefore, this procedure should only be used with special arrangements for clinical governance, consent and audit or research.

Source guidance details

Comes from guidance: Single-anastomosis duodeno-ileal bypass with sleeve gastrectomy for treating morbid obesity
Number: IPG569
Date issued: November 2016

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No
Last Reviewed	30/11/2016